“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...

Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.

GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using metformin, a new study has found.

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.